Skip to content
  • CONTACT
  • SUBSCRIBE
FacebookTwitterInstagramPinterestLinkedIn
Voyageur Pharmaceuticals Logo Voyageur Pharmaceuticals Logo Voyageur Pharmaceuticals Logo
  • OUR COMPANY
    • Our Company
    • Corporate Strategy
    • Officers & Directors
    • CEO’s Posts
    • Responsible Mining
  • PHARMACEUTICALS
    • Manufacturing Facilities
    • Our Products
    • Barium & Iodine Contrast Market and Sales Strategy
  • C60 THERAPEUTICS
    • C60 – What Is it?
      • C60
      • Information Links
      • Technical Reports
    • C60 Therapeutics
      • Natural Health Products
      • Radiographic Drug Development
      • Drug Development
  • OUR PROPERTIES
    • Our Properties
    • Lithium & Iodine
    • Frances Creek High Grade Discovery
    • Jubilee Mountain
    • Pedley Mountain
    • US Assets
    • Geology & Reports
    • Project Gallery
  • INVESTORS CENTRE
    • Investors Centre
    • Lithium & Iodine
    • Barite
    • Capital Structure
    • Ownership Opportunity
    • Corporate Presentations
    • Why Invest?
    • Common Questions
  • NEWS
  • CONTACT

Barite in the News

  • Light Scattering Grade Barium Sulfate
  • Natural gas expected to surpass coal in mix of fuel used for U.S. power generation in 2016
  • Schlumberger seeks barite mine approval
brent_adm2016-04-19T11:49:58-06:00

Office: + 403 923 5944
info@vpharma.ca

Suite 255, 339 50th Avenue SE
Calgary, Alberta T2G 2B3

Privacy Policy | Disclaimer

Go to Top